Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triamcinolone acetonide topical preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétonide de triamcinolone 40 mg/mL, seringue préremplie de 2 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/1mL i-m prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 10mg/1mL intra-articular/intradermal injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 50mg/5mL intra-articular/intradermal injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/1mL intra-articular/intramuscular inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 55microgram aqueous nasal spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 0.05% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 50mcg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 5 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 0.055mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 3mg injection suspension ampule 1mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 200mcg/spr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 55mcg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 100mcg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 55mcg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 50 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 0.055mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/mL injection suspension 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 40mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 80mg/mL injection suspension 0.1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/g oromucosal paste |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 50 milligram/5 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 50 milligram/5 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection syringe |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection syringe |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 55 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 55 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 10 milligram/1 milliliter conventional release suspension for injection ampule |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 10 milligram/1 milliliter conventional release suspension for injection ampule |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 80 milligram/2 milliliter conventional release suspension for injection syringe |
Has precise active ingredient |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 80 milligram/2 milliliter conventional release suspension for injection syringe |
Has basis of strength substance (attribute) |
False |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 10 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 10 mg/mL suspension for injection |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 5 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 5 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 50 microgram/actuation nasal spray |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamcinolone acetonide 50 microgram/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 3 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamcinolone acetonide 3 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely econazole nitrate 10 milligram/1 gram and triamcinolone acetonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely econazole nitrate 10 milligram/1 gram and triamcinolone acetonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone acetonide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |